| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41417-020-00219-Y |
| P698 | PubMed publication ID | 32895489 |
| P50 | author | Timothy Synold | Q78536675 |
| Karen Aboody | Q90051514 | ||
| Jana Portnow | Q96107473 | ||
| Massimo D'Apuzzo | Q96238840 | ||
| Revathiswari Tirughana | Q99207670 | ||
| Marianne Metz | Q99207671 | ||
| Julie Ressler | Q99207672 | ||
| P2093 | author name string | Behnam Badie | |
| M Suzette Blanchard | |||
| Vivi Tran | |||
| Shu Mi | |||
| Julie Kilpatrick | |||
| P2860 | cites work | Human neural stem cells expressing carboxyl esterase target and inhibit tumor growth of lung cancer brain metastases | Q39047939 |
| Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients. | Q39097305 | ||
| Pluripotent stem cells: A therapeutic source for age-related macular degeneration | Q39260912 | ||
| A dual PI3K/mTOR inhibitor, PI-103, cooperates with stem cell-delivered TRAIL in experimental glioma models | Q39630653 | ||
| Production and characterization of immortal human neural stem cell line with multipotent differentiation property | Q39998097 | ||
| Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling | Q40002631 | ||
| In-vitro differential metabolism and activity of 5-fluorouracil between short-term, high-dose and long-term, low-dose treatments in human squamous carcinoma cells | Q40301842 | ||
| Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents | Q40864715 | ||
| Risk of surgical site infection in 401 consecutive patients with glioblastoma with and without carmustine wafer implantation | Q41282346 | ||
| Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression | Q42835214 | ||
| Gene therapy of experimental brain tumors using neural progenitor cells | Q44761775 | ||
| Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study | Q45286242 | ||
| Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial | Q47232913 | ||
| NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. | Q48440226 | ||
| Genetically engineered human neural stem cells with rabbit carboxyl esterase can target brain metastasis from breast cancer | Q48932841 | ||
| Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project | Q68056139 | ||
| The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: results of a phase III trial. Swiss Group for Clinical Cancer Research (SAKK) | Q74754732 | ||
| A First-in-Human, Phase I Study of Neural Stem Cell Transplantation for Chronic Spinal Cord Injury | Q88957424 | ||
| Filling the Gap: Neural Stem Cells as A Promising Therapy for Spinal Cord Injury | Q91614573 | ||
| Current therapeutic developments in atrophic age-related macular degeneration | Q26778247 | ||
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
| Human nerual stem cells for brain repair | Q33614725 | ||
| Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study | Q33642314 | ||
| The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation | Q34013084 | ||
| A neuropharmacokinetic assessment of bafetinib, a second generation dual BCR-Abl/Lyn tyrosine kinase inhibitor, in patients with recurrent high-grade gliomas | Q34231554 | ||
| Neural stem cell-mediated intratumoral delivery of gold nanorods improves photothermal therapy. | Q34782994 | ||
| Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction. | Q34943738 | ||
| Oral versus intravenous flucytosine in patients with human immunodeficiency virus-associated cryptococcal meningitis. | Q35647796 | ||
| Systemic anticancer neural stem cells in combination with a cardiac glycoside for glioblastoma therapy | Q35679830 | ||
| Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas | Q35827956 | ||
| Human neural stem cells genetically modified for brain repair in neurological disorders | Q35918287 | ||
| Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model | Q35973436 | ||
| A pilot microdialysis study in brain tumor patients to assess changes in intracerebral cytokine levels after craniotomy and in response to treatment with a targeted anti-cancer agent | Q36090064 | ||
| Genetically engineered human neural stem cells for brain repair in neurological diseases | Q36736590 | ||
| A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy | Q36976226 | ||
| The timing of neural stem cell-based virotherapy is critical for optimal therapeutic efficacy when applied with radiation and chemotherapy for the treatment of glioblastoma | Q37124552 | ||
| Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide | Q37356520 | ||
| Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies | Q37396577 | ||
| Microdialysis for assessing intratumoral drug disposition in brain cancers: a tool for rational drug development | Q37714896 | ||
| Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes. | Q37734609 | ||
| Surgical Site Infection after Malignant Brain Tumor Resection: A Multicenter Study for Induction of a Basic Care Bundle | Q38651370 | ||
| Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study. | Q38753414 | ||
| The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary | Q38829244 | ||
| Neural stem cells preferentially migrate to glioma stem cells and reduce their stemness phenotypes | Q38961010 | ||
| P921 | main subject | neural stem cell | Q2944097 |
| P577 | publication date | 2020-09-08 | |
| P1433 | published in | Cancer Gene Therapy | Q15763088 |
| P1476 | title | Feasibility of intracerebrally administering multiple doses of genetically modified neural stem cells to locally produce chemotherapy in glioma patients |
Search more.